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Pheochromocytoma is a rare cause of hypertension in the general population. Only isolated reports show an association
with acute obstructive arterial thrombosis. A 50-year-old chronically noncompliant woman with a known unresected
pheochromocytoma presented to the emergency department with ataxia. Imaging conﬁrmed a right-sided ischemic stroke.
During her hospital stay, the patient developed signs consistent with acute right upper extremity ischemia resulting from
occlusion in the distal right subclavian, axillary, and proximal brachial arteries. Emergent open thrombectomy was
successfully performed. In patients with an unresected pheochromocytoma, one must consider acute arterial thrombosis
as a rare but potentially limb-threatening and even life-threatening complication. (J Vasc Surg 2013;58:1069-72.)Pheochromocytoma is a rare cause of hypertension in blood pressure (BP) of 200/130 mm Hg and ﬂuctuating weakness
the general population, representing <0.2% of cases.1 The
classic triad presentation consists of headaches, diaphoresis,
and palpitations. Although most do not present with this
triad, paroxysmal hypertension is found inw50% of patients.
Major complications, including papilledema, hypertensive
emergency, and cardiomyopathy, are the result of elevated
blood pressure and catecholamine excess.
Numerous published reports have documented the
association of pheochromocytoma with the development
of systemic and intracardiac thrombi.2-25 When present,
the intracardiac thrombus serves as a nidus for emboli to
the brain, kidneys, and distal extremities.2,3,7,9,23 Of the
28 patients reported in the literature, a left ventricle
thrombus was identiﬁed in only eight (Table). Inferior
vena cava (IVC) thrombi were present in 13 patients,
with some thrombi extending to the level of the right
atrium. Of note, the IVC thrombus in 11 of these patients
was due to direct tumor spread. Alternatively, only one case
report has documented an association between pheochro-
mocytoma and an isolated acute arterial thrombosis.11
We present the case of a 50-year-old woman with pheo-
chromocytoma who developed an acute occlusive arterial
thrombosis of the upper extremity.
CASE REPORT
A 50-year-old woman presented to the emergency department
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months earlier with a 7.8-cm pheochromocytoma in the left
adrenal gland. At the time of diagnosis, 24-hour urine studies
demonstrated elevated metanephrines (55,467 mg) and normeta-
nephrines (19,043 mg). In addition, plasma metanephrines and
normetanephrines were elevated at 82nM (normal <0.5nM) and
96nM (normal <0.5nM), respectively. Analysis of a percutaneous
biopsy specimen conﬁrmed the diagnosis of pheochromocytoma.
The patient left the hospital 4 days earlier, against medical
advice, after being admitted for a hypertensive emergency. During
the prior admission, she was being kept in the hospital to maintain
control of her BP before a planned resection of her tumor. The
patient was chronically noncompliant with medical therapy, which
resulted in multiple previous admissions for acute hypertensive
emergency that delayed a safe resection of the tumor. At the
time of this admission, she had not been taking her prescribed anti-
hypertensive medications. Her comorbidities included hypertro-
phic cardiomyopathy, seizures, and bipolar disorder.
Computed tomography (CT) scans and magnetic resonance
imaging (MRI) conﬁrmed a right-sided ischemic stroke in the par-
amedian parietal lobe. A carotid duplex examination at the time of
admission demonstrated 16% to 49% stenoses bilaterally. An echo-
cardiogram performed 3 days later showed a hyperdynamic left
ventricle with an ejection fraction of 70% to 75% and no evidence
of a ventricular thrombus.
While she was in the hospital, a change in mental status coin-
ciding with a systolic BP of 250 mm Hg required the patient to be
intubated for airway protection and to be transferred to the inten-
sive care unit. The BP was subsequently brought under control
using a continuous labetalol infusion. Six hours later, the patient’s
right arm was noted to be cold. Further examination demonstrated
a lack of pulses in the right radial, ulnar, brachial, and axillary
arteries. Duplex imaging conﬁrmed an acute occlusive thrombus
in the distal subclavian, axillary, and proximal brachial arteries.
After an evaluation by the neurology team and a discussion of
further management, the patient received a bolus of heparin, and
an intravenous heparin infusion was started.1069
Table. Literature review of thrombotic complications of pheochromocytoma in English language journals
Study Pts, No. Age, years Sex Size, cm Thrombus location
Current 1 50 F 7.8 Right subclavian to radial artery
Zhou2 1 43 F 4.0 Left ventricle
Hou3 1 47 F 8.0 Left ventricle, left axillary artery
Brauchlin4 1 51 M 8.0 Portal vein
Mrdovic5 1 53 F U Left ventricle
Kota6 1 48 M 7.6 IVC, right atrium
Dagartzikas7 1 13 M 8.5 Left ventricle
Stevenson8 1 46 M 9.0 Left femoral vein
Heindel9 1 49 M 10 Three left ventricle masses
Stella10 1 38 M 4-5 Cerebral venous thrombosis
Raghavan11 1 56 M 10 Right innominate and left common carotid arteries
Ku12 1 21 F 12 IVC, right atriumb
Lucon13 3 43 M 10.6 IVCb
46 M 8 IVCb
24 F 5.5 IVCb
Lucon14 1 43 M 6.5 IVCb
Dural15 1 17 M 10 IVC, right atriumb
Novick16 1 U U U IVCb
Pishdad17 1 18 F 8 Left ventricle
Robert18 1 43 M 7 Superior mesenteric vein
Rötker19 2 51 M 4.3 IVCb
58 F U IVC, right atriumb
Shigemura20 1 61 M 6 IVCb
Osman21 2 U M U Adrenal and renal vein
U M U Adrenal and renal vein
Wiyono22 1 43 M U Left ventricle
Yebra Yebra23 1 59 M 3.5 Left ventricle
Dunn24 1 57 M 10 IVCb
Shulkin25 1 32 M U IVC, right common femoral and inferior epigastric veins
BP, Blood pressure; F, female; FOD, found on diagnosis of tumor; IV, intravenous; IVC, inferior vena cava; LMWH, low-molecular-weight heparin; M, male;
Pts, patients; tPA, tissue plasminogen activator; U, unknown.
aAdequately controlled BP deﬁned as #140/80 mm Hg.
bRepresents direct tumor extension.
cAt 2 years after resection of primary tumor, patient developed metastatic disease and venous thrombosis.
dPatient with polycythemia and recurrent metastatic pheochromocytoma (ﬁrst diagnosed 21 years prior).
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anesthesia. A right brachial artery cutdown was performed, and a #3
Fogarty catheter was passed up to the level of the axillary artery.
Brisk, pulsatile ﬂow was noted after the thrombus was removed.
The thrombectomy was extended distally to the level of the radial
artery. No angiography was performed because of new-onset renal
failure. At the end of the procedure, there was return of a strong
palpable pulse. Intravenous heparin was continued postoperatively.
Four days later, the patient became unresponsive, prompting
a repeat CT scan, which demonstrated a large nonhemorrhagic
infarct in the right middle cerebral artery distribution. Because
no family members were involved and a conservator had not yet
been appointed, a decompressive hemicraniectomy was performed
for evidence of impending herniation. Although the patient’s
mental status improved, during the following weeks, she remained
hemiplegic and showed no improvement in ventilator status. Given
her terminal condition, the decision was made to withdraw
support, and the patient subsequently died.
DISCUSSION
The diagnosis of pheochromocytoma is challenging
because the symptoms can be episodic and the overall inci-
dence and index of suspicion is low. In most instances, BPcontrol is achieved by a blockade and the causative tumor
is resected. The complications resulting from catecholamine
excess are usually seen in those patients with a prolonged
workup before diagnosis or unresected disease. This was
particularly evident in our patient, who repeatedly was non-
compliant with outpatient BP management. In extreme
cases, one can consider admission to the hospital and even
intravenous medication use to obtain BP control before
surgery. However, as our patient demonstrated, even that
strategy can fail if a patient does not wish to comply with
the recommendations of his or her physicians to undergo
resective surgery.
One of the more common complications noted in
previous reports is the development of cardiomyopathy.
In addition to catecholamine-induced cardiomyopathy,
dilated and Takotsubo cardiomyopathy have also been re-
ported.26,27 Of those, only a small fraction are found to
have an intracardiac thrombus, the major risk being subse-
quent embolization to the brain, kidneys, and lower
extremities.2,3,7,9,23
An examination of the existing literature on throm-
botic complications of pheochromocytomas reveals several
notable observations. First, the ﬁrst major thrombotic
Emboli location Time to thrombosis Hormone secretion? BP controlled?a Anticoagulation management
None 6 months Yes Yes IV heparin
Bilateral femoral and renal arteries FOD U Yes Warfarin, urokinase
None FOD Yes Yes Warfarin, clopidogrel
None 4 years Yes No IV to unknown oral agent
None FOD Yes U IV heparin, aspirin
None FOD Yes No IV heparin, warfarin
Multiple cerebral emboli FOD Yes No TPA
None FOD Yes No LMWH, warfarin
Right cerebral and cerebellar arteries,
splenic artery, right femoral artery
FOD Yes No IV heparin, aspirin
None FOD Yes U Oral agent (U)
None FOD U U U
None FOD Yes No None
None FOD U U U
None U U U
None U U U
None FOD Yes Yes None
None FOD Yes U None
None U U U U
None FOD Yes U U
None FOD Yes U Yes, U med
None FOD Yes U None
None 2 yearsc U U None
None FOD Yes U None
None U U U U
None U U U U
None FOD U Yes Yes, U med
Left cerebral emboli FOD Yes No Heparin
None FOD Yes Yes None
None 21 yearsd U Yes IV heparin, warfarin
Table. Continued.
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time of tumor discovery. Second, of the thrombi that do
develop, 75% are located in the IVC or the heart, or
both. Further, of the 13 instances involving the IVC, 11
were due to direct tumor expansion. Most of the thrombi
were treated with systemic anticoagulation.
Finally, we note that the tumors in these studies are
quite large, ranging in size from 3.5 to 10.6 cm, with
only ﬁve being <6 cm. Pheochromocytomas classically
follow the “Rule of 10s”; that is, 10% are bilateral,
10% are malignant, 10% are pediatric cases, 10% are
extra-adrenal, and 10% are familial. Although increasing
size is often associated with an increased risk of malig-
nancy, in tumors with local disease only, a larger size
does not necessarily correlate with a higher likelihood
of malignancy.28
Venous thromboembolic disease is well described in
pheochromocytoma patients, but only one previous pub-
lished report showed an association with acute arterial
thrombi.11 When looking at all causes of large-vessel arte-
rial occlusive disease, an association has been shown with
inﬂammatory conditions, such as Buerger disease andﬁbromuscular dysplasia, but the overall incidence is low
and the presentation is not that of an acutely ischemic
limb. In addition, acute arterial ischemia affecting the
upper extremity is uncommon, occurring in only 10% to
20% of patients with acute arterial limb ischemia.
Studies have demonstrated that excess catecholamines
can directly contribute to hypercoagulability.29,30 Data
from ex vivo and numerous animal models demonstrate
inducible platelet aggregation resulting from catecholamine
infusion. Researchers in the United Kingdom demonstrated
that norepinephrine resulted in platelet aggregation in two
phases.31,32 Initially, the aggregation is reversible but
becomes irreversible after stimulated release of adenosine
diphosphate. The platelet aggregation is severe enough to
cause myocardial infarction and necrosis. Administration of
drugs inhibiting platelet aggregation prevents the formation
of thrombus, which further prevents development of
myocardial necrosis.
CONCLUSIONS
The high catecholamine state in patients with pheo-
chromocytoma can be very problematic. Complications,
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stroke, have been described. We present a patient who
developed an acute upper extremity arterial thrombosis
that required emergent intervention. Although this was
likely due to platelet aggregation stimulated by a surge in
catecholamine levels, we cannot rule out the possibility
of an embolus from a cardiac thrombus that was not visu-
alized on the echocardiogram. This complication is rare,
given that most patients undergo pheochromocytoma
tumor resection before encountering the multiple prob-
lems that our recalcitrant patient did. It is important
to remember that in patients with an unresected pheochro-
mocytoma, acute arterial thrombosis, although rare, can
occur. In addition, when an acute arterial thrombosis
occurs, particularly in an unusual location, as it did in our
patient, an undiagnosed pheochromocytoma should be
part of the differential diagnosis.
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